New Delhi, Feb. 17 -- The artificial intelligence (AI) solutions for medical imaging that are helping improve early detection and diagnosis of diseases such as tuberculosis, lung cancer, oncology, and cardiology conditions, impacting around 40 million people across more than 100 countries, said Ankit Modi, Qure.ai, Founding Member and Chief Product Officer (CPO).

Speaking to ANI during an exclusive conversation at the AI Impact Summit in Delhi, Ankit Modi said the company is showcasing its global healthcare impact and discussing international collaborations to improve population-level health screening.

"We build AI solutions for medical imaging, impacting oncology, cardiology, tuberculosis, and multiple disease areas. We are at the summ...